The new frontier of genome engineering with CRISPR-Cas9
The DOI matches its Crossref record; 153 of the 154 references it cites were found in a registry or an index.
Abstract
The advent of facile genome engineering using the bacterial RNA-guided CRISPR-Cas9 system in animals and plants is transforming biology. We review the history of CRISPR (clustered regularly interspaced palindromic repeat) biology from its initial discovery through the elucidation of the CRISPR-Cas9 enzyme mechanism, which has set the stage for remarkable developments using this technology to modify, regulate, or mark genomic loci in a wide variety of cells and organisms from all three domains of life. These results highlight a new era in which genomic manipulation is no longer a bottleneck to experiments, paving the way toward fundamental discoveries in biology, with applications in all branches of biotechnology, as well as strategies for human therapeutics.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Repurposing bacterial “CRISPR” systems to facilitate RNA-guided cleavage of complementary DNA has revolutionized the field of gene editing in mammalian cells 1–4.”
From A high-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human hematopoietic stem and progenitor cells (2018) · cites this paper as [3]
In the citing paper
“The CRISPR/Cas9 genome-editing system provides us an unprecedented opportunity to target and modify genomic sequences with high levels of efficacy and specificity [151,152,153,154,155].”
From Cell Immortality: In Vitro Effective Techniques to Achieve and Investigate Its Applications and Challenges (2024) · cites this paper as [152]
In the citing paper
“gene-editing techniques such as CRISPR-Cas9 [11], have led to a “democratization” of molecular biology, with functional and genomic analyses now possible in a wide range of species”
From Back to the Basics: Cnidarians Start to Fire (2017) · cites this paper as [11]
In the citing paper
“This outlook has changed dramatically in the last few years due to the introduction of novel methods that can be directly applied to a wide variety of species.”
From Back to the Basics: Cnidarians Start to Fire (2017) · cites this paper as [11]
In the citing paper
“Cas9:sgRNA recognizes the protospacer-adjacent motif (PAM) sequence and a complementary 20-nucleotide genomic sequence and induces double-strand DNA breaks, which are repaired by error-prone nonhomologous end-joining (NHEJ) or precise homology-directed repair (HDR)2,5.”
From Therapeutic genome editing by combined viral and non-viral delivery of CRISPR system components in vivo (2016) · cites this paper as [2]
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E. (2012) · Science · doi:10.1126/science.1225829 · Cited by 17,116
Self-citationMultiplex Genome Engineering Using CRISPR/Cas Systems
Cong, L., Ran, F. A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P. D., Wu, X., Jiang, W., Marraffini, L. A., et al. (2013) · Science · doi:10.1126/science.1231143 · Cited by 15,339
RNA-Guided Human Genome Engineering via Cas9
Mali, P., Yang, L., Esvelt, K. M., Aach, J., Guell, M., DiCarlo, J. E., Norville, J. E., & Church, G. M. (2013) · Science · doi:10.1126/science.1232033 · Cited by 9,210 · cited 5×
“Targeting with multiple sgRNAs—referred to as multiplexing—was also successfully achieved (75, 86).”
InfluentialCRISPR Provides Acquired Resistance Against Viruses in Prokaryotes
Barrangou, R., Fremaux, C., Deveau, H., Richards, M., Boyaval, P., Moineau, S., Romero, D. A., & Horvath, P. (2007) · Science · doi:10.1126/science.1138140 · Cited by 5,947 · cited 3×
“provided the first experimental evidence of CRISPRCas–mediated adaptive immunity (45).”
Development and Applications of CRISPR-Cas9 for Genome Engineering
Hsu, P. D., Lander, E. S., & Zhang, F. (2014) · Cell · doi:10.1016/j.cell.2014.05.010 · Cited by 5,762 · cited 2×
“Manyoftheseapplicationshavebeendiscussedinre-centreviews( 91 – 93 ).”
Genome-scale CRISPR-Cas9 knockout screening in human cells
Shalem, O., Sanjana, N. E., Hartenian, E., Shi, X., Scott, D. A., Mikkelsen, T. S., Heckl, D., Ebert, B. L., Root, D. E., Doench, J. G., et al. (2014) · Science · doi:10.1126/science.1247005 · Cited by 5,234 · cited 1×
“This approach was also used to identify genes essential for cell viability in cancer and pluripotent stem cells (102).”
Repurposing CRISPR as an RNA-Guided Platform for Sequence-Specific Control of Gene Expression
Qi, L. S., Larson, M. H., Gilbert, L. A., Doudna, J. A., Weissman, J. S., Arkin, A. P., & Lim, W. A. (2013) · Cell · doi:10.1016/j.cell.2013.02.022 · Cited by 5,016 · cited 1×
“coli, whole-genome sequencing showed that there were no detectable off-target effects (127).”
Self-citationDNA targeting specificity of RNA-guided Cas9 nucleases
Hsu, P. D., Scott, D. A., Weinstein, J. A., Ran, F. A., Konermann, S., Agarwala, V., Li, Y., Fine, E. J., Wu, X., Shalem, O., et al. (2013) · Nature Biotechnology · doi:10.1038/nbt.2647 · Cited by 4,741
CRISPR-Mediated Modular RNA-Guided Regulation of Transcription in Eukaryotes
Gilbert, L. A., Larson, M. H., Morsut, L., Liu, Z., Brar, G. A., Torres, S. E., Stern-Ginossar, N., Brandman, O., Whitehead, E. H., Doudna, J. A., et al. (2013) · Cell · doi:10.1016/j.cell.2013.06.044 · Cited by 3,696 · cited 1×
“Specifically, fusion of dCas9 to effector domains including VP64 or KRAB allowed stable and efficient transcriptional activation or repression, respectively, in human and yeast cells (129).”
Self-citationWang, H., Yang, H., Shivalila, C. S., Dawlaty, M. M., Cheng, A. W., Zhang, F., & Jaenisch, R. (2013) · Cell · doi:10.1016/j.cell.2013.04.025 · Cited by 3,495
Cited by
Items 401–500 of 1,072
Hultquist, J. F., Schumann, K., Woo, J. M., Manganaro, L., McGregor, M. J., Doudna, J., Simon, V., Krogan, N. J., & Marson, A. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.09.080 · Cited by 170
Self-citationCaplan, A. L., Parent, B., Shen, M., & Plunkett, C. (2015) · EMBO reports · doi:10.15252/embr.201541337 · Cited by 162
Basu, S., Aryan, A., Overcash, J. M., Samuel, G. H., Anderson, M. A. E., Dahlem, T. J., Myles, K. M., & Adelman, Z. N. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1502370112 · Cited by 166
“Previous studies that examined the promiscuity of the CRIPSRCas9 system have found evidence of a seed sequence of 8–12 bp largely responsible for DNA binding (38).”
BackgroundRestore or Redefine: Future Trajectories for Restoration
Coleman, M. A., Wood, G. V., Filbee‐Dexter, K., Minne, A. J. P., Goold, H. D., Vergés, A., Marzinelli, E. M., Steinberg, P. D., & Wernberg, T. (2020) · Frontiers in Marine Science · doi:10.3389/fmars.2020.00237 · Cited by 192
“The nature of these genetic elements could range from advantageous single nucleotide polymorphisms (SNPs; Doudna and Charpentier, 2014), to different genetic alleles/genes or even foreign/synthesized DNA (Williams et al., 2017), to larger duplications, inversions or deletions of entire chromosome…”
BackgroundInfluentialFungal Pigments: Potential Coloring Compounds for Wide Ranging Applications in Textile Dyeing
Venil, C. K., Velmurugan, P., Dufossé, L., Renuka Devi, P., & Veera Ravi, A. (2020) · Journal of Fungi · doi:10.3390/jof6020068 · Cited by 152
“This scaffold binds to target DNA whereas the guide RNA directs the Cas9 enzyme to make a cut at the right point, activating the DNA repair mechanism, and can be used to introduce changes to one or more genomes [121].”
BackgroundTargeting Brd4 for cancer therapy: inhibitors and degraders
Duan, Y., Guan, Y., Qin, W., Zhai, X., Yu, B., & Liu, H. (2018) · MedChemComm · doi:10.1039/c8md00198g · Cited by 161
An efficient CRISPR–Cas12a promoter editing system for crop improvement
Zhou, J., Liu, G., Zhao, Y., Zhang, R., Tang, X., Li, L., Jia, X., Guo, Y., Wu, Y., Han, Y., et al. (2023) · Nature Plants · doi:10.1038/s41477-023-01384-2 · Cited by 167
Shmakov, S. A., Makarova, K. S., Wolf, Y. I., Severinov, K. V., & Koonin, E. V. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1803440115 · Cited by 169
“In class 2 systems, including types II, V, and VI, all activities of the effector module reside in a single, large multidomain protein such as Cas9 in type II, the programmable endonuclease that is most widely used for genome-editing applications (2, 3, 13).”
Next-Generation Sequencing and Genome Editing in Plant Virology
Hadidi, A., Flores, R., Candresse, T., & Barba, M. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.01325 · Cited by 179
“Cas9 can be targeted to specific DNA genomic sequences by engineering separately an encoded small guide RNA (sgRNA) with which it forms a complex (Doudna and Charpentier, 2014).”
BackgroundSafety Aspects of Genetically Modified Lactic Acid Bacteria
Plavec, T. V., & Berlec, A. (2020) · Microorganisms · doi:10.3390/microorganisms8020297 · Cited by 156
“Cas9 uses a guide-RNA to form base pairs with the target DNA sequence, which is then followed by cleavage of this DNA and introduction of a site-specific double-strand break [44].”
BackgroundSuh, S., Choi, E. H., Leinonen, H., Foik, A. T., Newby, G. A., Yeh, W.-H., Dong, Z., Kiser, P. D., Lyon, D. C., Liu, D. R., et al. (2020) · Nature Biomedical Engineering · doi:10.1038/s41551-020-00632-6 · Cited by 163
Engineering microbial hosts for production of bacterial natural products
Zhang, M. M., Wang, Y., Ang, E. L., & Zhao, H. (2016) · Natural Product Reports · doi:10.1039/c6np00017g · Cited by 163
At Light Speed: Advances in Optogenetic Systems for Regulating Cell Signaling and Behavior
Repina, N. A., Rosenbloom, A., Mukherjee, A., Schaffer, D. V., & Kane, R. S. (2017) · Annual Review of Chemical and Biomolecular Engineering · doi:10.1146/annurev-chembioeng-060816-101254 · Cited by 162
“With the advent of CRISPR technology to specifically edit fusion genes into a genome of interest at the endogenous sites, stable cell lines can be more readily established with physiological levels of fusion protein expression (80).”
BackgroundEmerging therapies for mitochondrial diseases
Hirano, M., Emmanuele, V., & Quinzii, C. M. (2018) · Essays in Biochemistry · doi:10.1042/ebc20170114 · Cited by 162
RNA therapy: Are we using the right molecules?
Yu, A.-M., Jian, C., Yu, A. H., & Tu, M.-J. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.11.011 · Cited by 163
“…or progression may be directly altered by using a proper guide RNA (gRNA) and other necessary components to achieve a complete eradication of the disease for a patient (Doudna & Charpentier, 2014; Komor, Badran, & Liu, 2017; O'Day et al., 2018; Wang et al., 2017; Zhang, Wen, & Guo, 2014).”
BackgroundSequence features associated with the cleavage efficiency of CRISPR/Cas9 system
Liu, X., Homma, A., Sayadi, J., Yang, S., Ohashi, J., & Takumi, T. (2016) · Scientific Reports · doi:10.1038/srep19675 · Cited by 166
Dynamic Pluripotent Stem Cell States and Their Applications
Wu, J., & Izpisua Belmonte, J. C. (2015) · Cell Stem Cell · doi:10.1016/j.stem.2015.10.009 · Cited by 163
“With the advent of programmable nucleases including ZFNs, TALENs, and CAS, genome editing has become more precise and efficient (Doudna and Charpentier, 2014; Gaj et al., 2013).”
CRISPR/Cas9-mediated genome editing and gene replacement in plants: Transitioning from lab to field
Schaeffer, S. M., & Nakata, P. A. (2015) · Plant Science · doi:10.1016/j.plantsci.2015.09.011 · Cited by 160
Patterns of CRISPR/Cas9 activity in plants, animals and microbes
Bortesi, L., Zhu, C., Zischewski, J., Perez, L., Bassié, L., Nadi, R., Forni, G., Lade, S. B., Soto, E., Jin, X., et al. (2016) · Plant Biotechnology Journal · doi:10.1111/pbi.12634 · Cited by 161
“Cleavage occurs three nucleotides upstream of the PAM on both strands, mediated by the Cas9 endonuclease domains RuvC and HNH, respectively, introducing a precise double-strand break (DSB) with blunt ends that causes target DNA degradation (Chen and Gao, 2014; Doudna and Charpentier, 2014; Osakabe and Osakabe, 2015).”
BackgroundThe aerodynamics and control of free flight manoeuvres in Drosophila
Dickinson, M. H., & Muijres, F. T. (2016) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2015.0388 · Cited by 162
“The advent of transgenic techniques such as the CRISPR/Cas9 system [6] will soon allow researchers to pursue questions in these non-genetic model species at finer levels of granularity, as is already happening in mosquitos [7,8].”
BackgroundEfficient genome editing in Fusarium oxysporum based on CRISPR/Cas9 ribonucleoprotein complexes
Wang, Q., Cobine, P. A., & Coleman, J. J. (2018) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2018.05.003 · Cited by 163
“The main benefits of this gene disruption/deletion system are accurate gene modification and highly successful mutation rates (Doudna and Charpentier, 2014; Ran et al., 2013).”
BackgroundAthrey, G. (2020) · Animal Agriculture · doi:10.1016/b978-0-12-817052-6.00018-5 · Cited by 158
SapTrap, a Toolkit for High-Throughput CRISPR/Cas9 Gene Modification in Caenorhabditis elegans
Schwartz, M. L., & Jorgensen, E. M. (2016) · Genetics · doi:10.1534/genetics.115.184275 · Cited by 168
Delivery approaches for CRISPR/Cas9 therapeutics in vivo: advances and challenges
Luther, D. C., Lee, Y. W., Nagaraj, H., Scaletti, F., & Rotello, V. M. (2018) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2018.1517746 · Cited by 153
TALENs—an indispensable tool in the era of CRISPR: a mini review
Bhardwaj, A., & Nain, V. (2021) · Journal of Genetic Engineering and Biotechnology · doi:10.1186/s43141-021-00225-z · Cited by 182
Trovão, M., Schüler, L. M., Machado, A., Bombo, G., Navalho, S., Barros, A., Pereira, H., Silva, J., Freitas, F., & Varela, J. (2022) · Marine Drugs · doi:10.3390/md20070440 · Cited by 155
Paunovska, K., Gil, C. J., Lokugamage, M. P., Sago, C. D., Sato, M., Lando, G. N., Gamboa Castro, M., Bryksin, A. V., & Dahlman, J. E. (2018) · ACS Nano · doi:10.1021/acsnano.8b03640 · Cited by 160
Multiplex Conditional Mutagenesis Using Transgenic Expression of Cas9 and sgRNAs
Yin, L., Maddison, L. A., Li, M., Kara, N., LaFave, M. C., Varshney, G. K., Burgess, S. M., Patton, J. G., & Chen, W. (2015) · Genetics · doi:10.1534/genetics.115.176917 · Cited by 152
“CRISPR/Cas9 mutagenesis has been applied to many model systems from cultured cells to whole organisms (Doudna and Charpentier 2014; Hsu et al. 2014).”
BackgroundRoberts, D. P., & Mattoo, A. K. (2018) · Agriculture · doi:10.3390/agriculture8010008 · Cited by 174
“Also, transgenic tobacco, rice, and tomato plants engineered to express heterologous S-adenosylmethionine decarboxylase gene, a rate-limiting enzyme/gene in polyamine biosynthesis [100], showed tolerance against salt, osmotic, and heat stresses [139,155–158], while overexpression of spermidine synthase gene—in Arabido…”
BackgroundCRISPR/Cas9-mediated genome editing in a reef-building coral
Cleves, P. A., Strader, M. E., Bay, L. K., Pringle, J. R., & Matz, M. V. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1722151115 · Cited by 180
Linares, A. J., Lin, C.-H., Damianov, A., Adams, K. L., Novitch, B. G., & Black, D. L. (2015) · eLife · doi:10.7554/elife.09268 · Cited by 155
“To examine the role of Pbx1a repression, we modified the Pbx1 locus using the CRISPR-Cas9 technology to force exon 7 splicing in cells containing PTBP1 (Doudna and Charpentier, 2014; Cong and Zhang, 2015e).”
MethodMitochondrial Mechanisms of Neuronal Cell Death: Potential Therapeutics
Dawson, T. M., & Dawson, V. L. (2017) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010716-105001 · Cited by 159
CRISPR/Cas9 in insects: Applications, best practices and biosafety concerns
Taning, C. N. T., Eynde, B. V., Yu, N., Ma, S., & Smagghe, G. J. (2017) · Journal of Insect Physiology · doi:10.1016/j.jinsphys.2017.01.007 · Cited by 170
Current and innovative methods for the diagnosis of COVID‑19 infection (Review)
Falzone, L., Gattuso, G., Tsatsakis, A. M., Spandidos, D. A., & Libra, M. (2021) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2021.4933 · Cited by 183
Hachem, A., Godwin, J., Ruas, M., Lee, H. C., Ferrer Buitrago, M., Ardestani, G., Bassett, A., Fox, S., Navarrete, F., de Sutter, P., et al. (2017) · Development · doi:10.1242/dev.150227 · Cited by 157
“Here, we describe the generation of such a PLC ζ -null mouse through CRISPR/Cas9 gene editing (Doudna and Charpentier, 2014), and its phenotypic analysis.”
Ultrasonically Propelled Micro‐ and Nanorobots
Li, J., Mayorga‐Martinez, C. C., Ohl, C., & Pumera, M. (2021) · Advanced Functional Materials · doi:10.1002/adfm.202102265 · Cited by 166
A large-scale resource for tissue-specific CRISPR mutagenesis in Drosophila
Port, F., Strein, C., Stricker, M., Rauscher, B., Heigwer, F., Zhou, J., Beyersdörffer, C., Frei, J., Hess, A., Kern, K., et al. (2020) · eLife · doi:10.7554/elife.53865 · Cited by 158
“Clustered Regularly Interspersed Short Palindromic Repeats (CRISPR) - CRISPR-associated (Cas) systems are adaptive prokaryotic immune systems that have been adopted for genome engineering applications (Doudna and Charpentier, 2014; Wang et al., 2016).”
BackgroundUbiquitylation, neddylation and the DNA damage response
Brown, J. S., & Jackson, S. P. (2015) · Open Biology · doi:10.1098/rsob.150018 · Cited by 147
Current Status and Challenges of DNA Base Editing Tools
Jeong, Y. K., Song, B., & Bae, S. (2020) · Molecular Therapy · doi:10.1016/j.ymthe.2020.07.021 · Cited by 164
The Cancer Cell Map Initiative: Defining the Hallmark Networks of Cancer
Krogan, N. J., Lippman, S., Agard, D. A., Ashworth, A., & Ideker, T. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.05.008 · Cited by 149
“For example, CRISPR/Cas9 technology permits facile labeling of genes with affinity tags and the engineering of specific point mutants into the genomes of mammalian somatic cells (Doudna and Charpentier, 2014) or induced pluripotent stem cells (iPS cells) (Yamanaka, 2009).”
BackgroundCas9-mediated genome editing in the methanogenic archaeon Methanosarcina acetivorans
Nayak, D. D., & Metcalf, W. W. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1618596114 · Cited by 154
“Alternatively, the native homology-dependent repair (HDR) pathway can repair the fatal DSB, so long as a repair template that modifies or removes the sgRNA target site is provided, again preventing additional rounds of Cas9-mediated cleavage (3, 5) (Fig.”
BackgroundInfluentialChen, F., Ding, X., Feng, Y., Seebeck, T., Jiang, Y., & Davis, G. D. (2017) · Nature Communications · doi:10.1038/ncomms14958 · Cited by 157
Perspective: The promise of multi-cellular engineered living systems
Kamm, R. D., Bashir, R., Arora, N., Dar, R. D., Gillette, M. U., Griffith, L. G., Kemp, M. L., Kinlaw, K., Levin, M., Martin, A. C., et al. (2018) · APL Bioengineering · doi:10.1063/1.5038337 · Cited by 154
Recent advances in activating silent biosynthetic gene clusters in bacteria
Mao, D., Okada, B. K., Wu, Y., Xu, F. Y., & Seyedsayamdost, M. R. (2018) · Current Opinion in Microbiology · doi:10.1016/j.mib.2018.05.001 · Cited by 158
Deciphering Off-Target Effects in CRISPR-Cas9 through Accelerated Molecular Dynamics
Ricci, C. G., Chen, J. S., Miao, Y., Jinek, M., Doudna, J. A., McCammon, J. A., & Palermo, G. (2019) · ACS Central Science · doi:10.1021/acscentsci.9b00020 · Cited by 145
Self-citationSheng, Y., Zhang, T., Zhang, S., Johnston, M., Zheng, X., Shan, Y., Liu, T., Huang, Z., Qian, F., Xie, Z., et al. (2021) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2021.113027 · Cited by 160
Structural basis for the altered PAM specificities of engineered CRISPR-cas9
Hirano, S., Nishimasu, H., Ishitani, R., & Nureki, O. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.02.018 · Cited by 152
Statistical inference as severe testing how to get beyond the statistics wars
Mayo, D. G. (2018) · Cited by 159
Programmable base editing of mutated TERT promoter inhibits brain tumour growth
Li, X., Qian, X., Wang, B., Xia, Y., Zheng, Y., Du, L., Xu, D., Xing, D., DePinho, R. A., & Lu, Z. (2020) · Nature Cell Biology · doi:10.1038/s41556-020-0471-6 · Cited by 163
Modern Strategies to Assess and Breed Forest Tree Adaptation to Changing Climate
Cortés, A. J., Restrepo-Montoya, M., & Bedoya-Canas, L. E. (2020) · Frontiers in Plant Science · doi:10.3389/fpls.2020.583323 · Cited by 161
“Gene editing (Doudna and Charpentier, 2014; Dort et al., 2020) and transgenics (Campbell et al., 2003) can also transfer or silence allelic variants of major effects within a single generation (Pereira-Lorenzo et al., 2019).”
BackgroundSynthetic Biology: Bottom-Up Assembly of Molecular Systems
Hirschi, S., Ward, T. R., Meier, W. P., Müller, D. J., & Fotiadis, D. (2022) · Chemical Reviews · doi:10.1021/acs.chemrev.2c00339 · Cited by 157
Insert, remove or replace: A highly advanced genome editing system using CRISPR/Cas9
Ceasar, S. A., Rajan, V., Prykhozhij, S. V., Berman, J. N., & Ignacimuthu, S. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2016.06.009 · Cited by 151
Pacher, M., & Puchta, H. (2017) · The Plant Journal · doi:10.1111/tpj.13469 · Cited by 145
Recent advances and applications of CRISPR-Cas9 in cancer immunotherapy
Liu, Z., Shi, M., Ren, Y., Xu, H., Weng, S., Ning, W., Ge, X., Liu, L., Guo, C., Duo, M., et al. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01738-6 · Cited by 177
Graphene oxide-mediated Cas9/sgRNA delivery for efficient genome editing
Yue, H., Zhou, X., Cheng, M., & Xing, D. (2018) · Nanoscale · doi:10.1039/c7nr07999k · Cited by 150
The pathobiology of pig‐to‐primate xenotransplantation: a historical review
Cooper, D. K. C., Ezzelarab, M. B., Hara, H., Iwase, H., Lee, W., Wijkstrom, M. N., & Bottino, R. (2016) · Xenotransplantation · doi:10.1111/xen.12219 · Cited by 159
Bode, L., Contractor, N., Barile, D., Pohl, N., Prudden, A. R., Boons, G.-J., Jin, Y.-S., & Jennewein, S. (2016) · Nutrition Reviews · doi:10.1093/nutrit/nuw025 · Cited by 144
“In addition, rapid advances in genome engineering 52 have enabled a more targeted gene-editing approach with limited off-target effects, thus providing an effective method for obtaining safe, genetically modified strains in the near future.”
Nucleus of the Solitary Tract Serotonin 5-HT2C Receptors Modulate Food Intake
D'Agostino, G., Lyons, D., Cristiano, C., Lettieri, M., Olarte-Sanchez, C., Burke, L. K., Greenwald-Yarnell, M., Cansell, C., Doslikova, B., Georgescu, T., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.07.017 · Cited by 149
“To knock down POMCARC, we employed the clustered, regularly interspaced, short palindromic repeats (CRISPR) and associated endonuclease 9 (Cas9) gene-editing technique (Doudna and Charpentier, 2014; Hsu et al., 2014).”
MethodImmunity to CRISPR Cas9 and Cas12a therapeutics
Chew, W. L. (2018) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.1408 · Cited by 147
Chen, L., Qu, J., Cheng, T., Chen, X., & Xiang, C. (2019) · Stem Cell Research & Therapy · doi:10.1186/s13287-019-1503-7 · Cited by 149
“CRISPR/Cas9 is a recently discovered novel genome editing technology that is widely used in genetic modification, transcriptional regulation, and gene therapy [65].”
Ramakrishnan, M., Yrjälä, K., Vinod, K. K., Sharma, A., Cho, J., Satheesh, V., & Zhou, M. (2020) · Food and Energy Security · doi:10.1002/fes3.229 · Cited by 167
“Latest advancements in gene editing technologies have found increasing use of clustered regularly interspaced short palindromic repeat (CRISPR)–CRISPR-associated endonuclease (Cas9) system in several crop species (Doudna & Charpentier, 2014).”
BackgroundTang, F., Yang, S., Liu, J., & Zhu, H. (2015) · PLANT PHYSIOLOGY · doi:10.1104/pp.15.01661 · Cited by 157
“Glyma.01G165800-D But Not Glyma.01G165800 Is Required for Rj4-Mediated Nodulation Restriction We used the CRISPR/Cas9-based reverse genetics tool (Doudna and Charpentier, 2014) to knock out the Glyma.01G165800 and Glyma.01G165800-D genes in the Hill (Rj4/Rj4) genetic background.”
MethodGenome Editing in Plants: An Overview of Tools and Applications
Kamburova, V., Nikitina, E. V., Shermatov, S. E., Buriev, Z. T., Kumpatla, S. P., Emani, C., & Abdurakhmonov, I. Y. (2017) · International Journal of Agronomy · doi:10.1155/2017/7315351 · Cited by 161
CRISPR/Cas9 technology as a potent molecular tool for gene therapy
Karimian, A., Azizian, K., Parsian, H., Rafieyan, S., Shafiei‐Irannejad, V., Kheyrollah, M., Yousefi, M., Majidinia, M., & Yousefi, B. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.27972 · Cited by 163
“Moreover, ZFN and TALEN are more labor‐intensive and expensive in comparison with the CRISPR‐Cas9 technology (Doudna & Charpentier, 2014; Schmidt & Grimm, 2015).”
BackgroundTowards application of CRISPR-Cas12a in the design of modern viral DNA detection tools (Review)
Dronina, J., Samukaitė-Bubnienė, U., & Ramanavičius, A. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01246-7 · Cited by 151
Non-viral delivery of the CRISPR/Cas system: DNA versus RNA versus RNP
Lin, Y., Wagner, E., & Lächelt, U. (2022) · Biomaterials Science · doi:10.1039/d1bm01658j · Cited by 155
Wyvekens, N., Topkar, V. V., Khayter, C., Joung, J. K., & Tsai, S. Q. (2015) · Human Gene Therapy · doi:10.1089/hum.2015.084 · Cited by 142
Josephs, E. A., Kocak, D. D., Fitzgibbon, C. J., McMenemy, J., Gersbach, C. A., & Marszalek, P. E. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv892 · Cited by 142
“The role of this second transition was suggested to be related to strand invasion by sgRNA (43) or to align the two major Cas9 nuclease sites with the two separated DNA strands (35,44).”
Backgroundvon Kamp, A., & Klamt, S. (2017) · Nature Communications · doi:10.1038/ncomms15956 · Cited by 160
HP1α is a chromatin crosslinker that controls nuclear and mitotic chromosome mechanics
Strom, A. R., Biggs, R. J., Banigan, E. J., Wang, X., Chiu, K., Herman, C., Collado, J., Yue, F., Ritland Politz, J. C., Tait, L. J., et al. (2021) · eLife · doi:10.7554/elife.63972 · Cited by 146
Hypoxia‐Responsive Gene Editing to Reduce Tumor Thermal Tolerance for Mild‐Photothermal Therapy
Li, X., Pan, Y., Chen, C., Gao, Y., Liu, X., Yang, K., Luan, X., Zhou, D., Zeng, F., Han, X., et al. (2021) · Angewandte Chemie International Edition · doi:10.1002/anie.202107036 · Cited by 148
Li, F., Song, N., Dong, Y., Li, S., Li, L., Liu, Y., Li, Z., & Yang, D. (2022) · Angewandte Chemie International Edition · doi:10.1002/anie.202116569 · Cited by 156
Microalgae with Artificial Intelligence: A Digitalized Perspective on Genetics, Systems and Products
Teng, S. Y., Yew, G. Y., Sukačová, K., Show, P. L., Máša, V., & Chang, J.-S. (2020) · Biotechnology Advances · doi:10.1016/j.biotechadv.2020.107631 · Cited by 145
Kim, H. K., Lee, S., Kim, Y., Park, J., Min, S., Choi, J. W., Huang, T. P., Yoon, S., Liu, D. R., & Kim, H. H. (2020) · Nature Biomedical Engineering · doi:10.1038/s41551-019-0505-1 · Cited by 145
Haziza, S., Mohan, N., Loe-Mie, Y., Lepagnol-Bestel, A.-M., Massou, S., Adam, M., Xuan, L. L., Viard, J., Plançon, C., Daudin, R., et al. (2016) · Nature Nanotechnology · doi:10.1038/nnano.2016.260 · Cited by 151
Targeted mutagenesis in wheat microspores using CRISPR/Cas9
Bhowmik, P., Ellison, E., Polley, B., Bollina, V., Kulkarni, M., Ghanbarnia, K., Song, H., Gao, C., Voytas, D. F., & Kagale, S. (2018) · Scientific Reports · doi:10.1038/s41598-018-24690-8 · Cited by 143
Advances in CRISPR/Cas-based Gene Therapy in Human Genetic Diseases
Wu, S.-S., Li, Q.-C., Yin, C.-Q., Xue, W., & Song, C.-Q. (2020) · Theranostics · doi:10.7150/thno.43360 · Cited by 131
“The CRISPR/Cas system has rapidly become the most popular genome editing platform due to its simplicity and adaptability [2-5].”
BackgroundHarnessing Crop Wild Diversity for Climate Change Adaptation
Cortés, A. J., & López-Hernández, F. (2021) · Genes · doi:10.3390/genes12050783 · Cited by 166
Back to the Basics: Cnidarians Start to Fire
Bosch, T. C. G., Klimovich, A., Domazet-Lošo, T., Gründer, S., Holstein, T. W., Jékely, G., Miller, D. J., Murillo-Rincon, A. P., Rentzsch, F., Richards, G. S., et al. (2017) · Trends in Neurosciences · doi:10.1016/j.tins.2016.11.005 · Cited by 144
“This, together with gene-editing techniques such as CRISPR/Cas9 [11], have led to a ‘democratization’ of molecular biology, with functional and genomic analyses now possible in a wide range of species.”
MethodLi, J., Shou, J., Guo, Y., Tang, Y., Wu, Y., Jia, Z., Zhai, Y., Chen, Z., Xu, Q., & Wu, Q. (2015) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjv016 · Cited by 138
“Gene editing utilizing NHEJ with artificial DSBs induced by ZFN, TALEN, or CRISPR has advanced rapidly (Carroll, 2014; Doudna and Charpentier, 2014; Harrison et al., 2014).”
BackgroundOhmori, T., Nagao, Y., Mizukami, H., Sakata, A., Muramatsu, S., Ozawa, K., Tominaga, S., Hanazono, Y., Nishimura, S., Nureki, O., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-04625-5 · Cited by 151
CRISPR-based detection of SARS-CoV-2: A review from sample to result
Nouri, R., Tang, Z., Dong, M., Liu, T., Kshirsagar, A., & Guan, W. (2021) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2021.113012 · Cited by 146
“In the past few years, the emergence and development of clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPRassociated Cas proteins opened a new avenue of research towards molecular diagnostics (Doudna and Charpentier 2014).”
BackgroundBauer, D. E., & Orkin, S. H. (2015) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2015.08.001 · Cited by 143
“Rapid progress in genome editing tools, particularly with the RNA-guided CRISPR/Cas systems, has made precise genome modification increasingly plausible in clinical settings [67,68].”
BackgroundRecent Advances in Genome Editing Using CRISPR/Cas9
Ding, Y., Li, H., Chen, L.-L., & Xie, K. (2016) · Frontiers in Plant Science · doi:10.3389/fpls.2016.00703 · Cited by 129
“The advanced CRISPR/Cas9 technology not only provides a molecular tool for investigating biological questions in depth, but also enables the development of innovative and practical applications of biology (Pennisi, 2013; Doudna and Charpentier, 2014; Hsu et al., 2014).”
BackgroundComparative assessment of fluorescent proteins for in vivo imaging in an animal model system
Heppert, J. K., Dickinson, D. J., Pani, A. M., Higgins, C. D., Steward, A., Ahringer, J., Kuhn, J. R., & Goldstein, B. (2016) · Molecular Biology of the Cell · doi:10.1091/mbc.e16-01-0063 · Cited by 162
“…techniques based on the CRISPR/Cas9 system have recently made it possible to more precisely edit the genomes of diverse cell types and organisms (Doudna and Charpentier, 2014; Gilles and Averof, 2014; Harrison et al., 2014; Hsu et al., 2014; Peng et al., 2014) and to routinely insert…”
BackgroundMethodCRISPR-Based Technologies for Metabolic Engineering in Cyanobacteria
Behler, J., Vijay, D., Hess, W. R., & Akhtar, M. K. (2018) · Trends in Biotechnology · doi:10.1016/j.tibtech.2018.05.011 · Cited by 138
CRISPR-Cas in Streptococcus pyogenes
Rhun, A. L., Escalera-Maurer, A., Bratovič, M., & Charpentier, E. (2019) · RNA Biology · doi:10.1080/15476286.2019.1582974 · Cited by 162
Self-citationZheng, Y., Han, J., Liang, W., Li, R., Hu, X., Wang, B., shen, W., Ma, L., Ma, L., Yi, L., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz940 · Cited by 146
Engineering Multiple Abiotic Stress Tolerance in Canola, Brassica napus
Lohani, N., Jain, D., Singh, M. B., & Bhalla, P. L. (2020) · Frontiers in Plant Science · doi:10.3389/fpls.2020.00003 · Cited by 152
Biosystems Design by Machine Learning
Volk, M., Lourentzou, I., Mishra, S., Vo, L. T., Zhai, C., & Zhao, H. (2020) · ACS Synthetic Biology · doi:10.1021/acssynbio.0c00129 · Cited by 164
Green technology for the industrial production of biofuels and bioproducts from microalgae: A review
Tang, D. Y. Y., Yew, G. Y., Koyande, A. K., Chew, K. W., Vo, D.-V. N., & Show, P. L. (2020) · Environmental Chemistry Letters · doi:10.1007/s10311-020-01052-3 · Cited by 142
The chemistry of Cas9 and its CRISPR colleagues
Chen, J. S., & Doudna, J. A. (2017) · Nature Reviews Chemistry · doi:10.1038/s41570-017-0078 · Cited by 152
Self-citationThe genomes of pecan and Chinese hickory provide insights into Carya evolution and nut nutrition
Huang, Y., Xiao, L., Zhang, Z., Zhang, R., Wang, Z., Huang, C., Huang, R., Luan, Y., Fan, T., Wang, J., et al. (2019) · GigaScience · doi:10.1093/gigascience/giz036 · Cited by 152
“…of abiotic and biotic stress tolerance, yield, and nutrition in hickories and offer great potential for genome-based breeding of superior cultivars in the genus Carya , with the aid of the established explant regeneration techniques [31, 32], and advanced CRISPR-Cas9 gene-editing techniques [33].”
The Caenorhabditis elegans Transgenic Toolbox
Nance, J., & Frøkjær‐Jensen, C. (2019) · Genetics · doi:10.1534/genetics.119.301506 · Cited by 160
Ali, Z., Shami, A., Sedeek, K., Kamel, R., Alhabsi, A., Tehseen, M., Hassan, N., Butt, H., Kababji, A., Hamdan, S. M., et al. (2020) · Communications Biology · doi:10.1038/s42003-020-0768-9 · Cited by 139
Belwal, T., Singh, G., Jeandet, P., Pandey, A., Giri, L., Ramola, S., BHATT, I. D., Venskutonis, P. R., Georgiev, M. I., Clément, C., et al. (2020) · Biotechnology Advances · doi:10.1016/j.biotechadv.2020.107600 · Cited by 148
Wei, T., Cheng, Q., Farbiak, L., Anderson, D. G., Langer, R., & Siegwart, D. J. (2020) · ACS Nano · doi:10.1021/acsnano.0c04707 · Cited by 135
Maioli, A., Gianoglio, S., Moglia, A., Acquadro, A., Valentino, D., Milani, A. M., Prohens, J., Orzáez, D., Granell, A., Lanteri, S., et al. (2020) · Frontiers in Plant Science · doi:10.3389/fpls.2020.607161 · Cited by 160
“…makes it possible to induce point mutations in one or multiple target sequences simultaneously, as well as to introduce new genetic variants through homology directed recombination (HDR), or to modulate transcription and chromatin structure at selected target loci (Doudna and Charpentier, 2014).”
BackgroundProtospacer Adjacent Motif-Induced Allostery Activates CRISPR-Cas9
Palermo, G., Ricci, C. G., Fernando, A., Basak, R., Jinek, M., Rivalta, I., Batista, V. S., & McCammon, J. A. (2017) · Journal of the American Chemical Society · doi:10.1021/jacs.7b05313 · Cited by 138
Shanthinie, A., Jaganathan, D., Ramanathan, V., Rahman, H., Palaniswamy, R., Kambale, R., & Raveendran, M. (2020) · PLoS ONE · doi:10.1371/journal.pone.0237018 · Cited by 140
“…Zinc finger nucleases (ZFNs), Transcription Activator Like effector nucleases (TALENs) and Clustered Regulatory Interspaced Short Palindromic Repeats (CRISPR) associated (CRISPR/Cas), CRISPR/Cas is preferred over other site specific nucleases due to its simplicity, flexibility and accuracy [53].”
Metadata
- Authors
- Doudna, J. A., & Charpentier, E.
- Affiliations
- Howard Hughes Medical Institute (US)
- Medizinische Hochschule Hannover (DE)
- Corresponding author
- Doudna, Jennifer A.
- Charpentier, Emmanuelle
- Venue
- Science
- Published
- 2014-11-28
- Volume
- 346
- Issue
- 6213
- Pages
- 1258096-1258096
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2050480410
- Semantic Scholar
- e138728065ae7707ff75c3b6a5a52e81856ccf1b
- Cited by
- 7,062
- References
- 154
- Citations by year
- 2026: 560 · 2025: 716 · 2024: 665 · 2023: 580 · 2022: 689 · 2021: 700 · 2020: 653 · 2019: 578 · 2018: 569 · 2017: 545 · 2016: 471 · 2015: 314 · 2014: 3
- FWCI
- 41.84
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Howard Hughes Medical Institute
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
- Keywords
- CRISPR/Cas9, genome editing, RNA-guided genome editing, genome modification, genome regulation, biotechnology applications, human therapeutics
- MeSH terms
- Animals, Genetic Engineering, Humans, Genome, Human, Gene Targeting, DNA Cleavage, RNA, Small Untranslated, Clustered Regularly Interspaced Short Palindromic Repeats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.